Urgent Action Required to Maintain Our Medical Freedom to Choose
|

Urgent Action Required to Maintain Our Medical Freedom to Choose

FYI & Action History is repeating itself! Once again, a massive propaganda machine has fomented disease hysteria, preempting rational public health policy decisions. Last time around, coercive medical sterilizations were performed in the U.S.; their goal was to “cleanse the genetic pool of undesirables”. This time around, the objective is…

BioMedNet: FDA Divorces Chemistry from Biology

Subject: BioMedNet: FDA Divorces Chemistry from Biology Date: Sun, 15 Sep 2002 10:25:07 -0400 FDA maintains two administrative oversight branches for medical products: Center for Biologics Evaluation and Research (CBER)–is responsible for overseeing the safety of bio-tech based therapies, vaccines, blood safety, and gene therapy. Center for Drug Evaluation and…

Drugmakers Go Furthest to Sway Congress: 1,274 Lobbyists – USA Today

Drugmakers Go Furthest to Sway Congress: 1,274 Lobbyists – USA Today Tue, 26 Apr 2005 USA Today provides a glimpse into the way the pharmaceutical industry controls health care policy by buying influence at the highest level of government, and underwriting professional and lay healthcare organizations whose spokespersons parrot industry’s…

FDA acknowledges failure to act as defibrillator malfunction increased

FDA acknowledges failure to act as defibrillator malfunction increased: 4,225 failed between 2000–2003 Sat, 17 Sep 2005 The Washington Post reports that the number of failed heart defibrillators is increasing: “William H. Maisel, the Harvard Medical School physician who conducted the FDA study, said the increase is significant and contrasts…

TIME inquiry finds top officials at vital gov agencies lack credentials for the job

TIME inquiry finds top officials at vital gov agencies lack credentials for the job Date: Wed, 28 Sep 2005 The New York Times reports today that the mystery of Lester Crawford’s abrupt resignation as head of the FDA “fueled speculation that he had investments in companies regulated by the FDA."…

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden resignation of FDA Commissioner, Lester Crawford, after just two months in office, has prompted a bipartisan Senate investigation and requests both by the Senate committee HELP and by congressman Maurice Hinchey (NY) and…